Overview
Darmiyan develops machine learning-powered diagnostic solutions for early detection and monitoring of brain health conditions, including mild cognitive impairment, utilizing advanced radiology analysis on cloud-based platforms. The company's technology enables healthcare providers to support brain longevity and cognitive health through AI-driven screening and continuous patient monitoring.
More in Neurotechnology
Latest industry news
Flourish Emerges from Stealth with Bezos and Google Ventures Backing to Target Brain Health
2026-07-11 · Funding
BrainCo Pushes to Commercialize Brain-Tech as China's BCI Ambitions Come Into Focus
2026-07-10 · Industry
FDA Clears PoNS Device for Stroke Rehabilitation, Broadening Neurostimulation's Clinical Reach
2026-07-09 · Policy
Neurovalens Wins FDA Approval for PTSD Therapy Targeting US Veterans
2026-07-08 · Policy
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →